These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 7934146)
1. Characterization of newly established adriamycin resistant human leukemic cell lines (KY-ADR1 and KY-ADR2). Fukuda T; Kakihara T; Kamishima T; Ohnishi Y; Naito M; Kishi K; Shibata A; Tsuruo T Leuk Res; 1994 Sep; 18(9):709-15. PubMed ID: 7934146 [TBL] [Abstract][Full Text] [Related]
2. Experimental models for the study of drug resistance in osteosarcoma: P-glycoprotein-positive, murine osteosarcoma cell lines. Takeshita H; Gebhardt MC; Springfield DS; Kusuzaki K; Mankin HJ J Bone Joint Surg Am; 1996 Mar; 78(3):366-75. PubMed ID: 8613443 [TBL] [Abstract][Full Text] [Related]
3. Characterization of newly established human myeloid leukemia cell line (KF-19) and its drug resistant sublines. Fukuda T; Kamishima T; Kakihara T; Ohnishi Y; Suzuki T Leuk Res; 1996; 20(11-12):931-9. PubMed ID: 9009251 [TBL] [Abstract][Full Text] [Related]
4. Different effects of various hematopoietic growth factors on myelomonocytic cell line (KY-821) and its drug-resistant sublines. Fukuda T; Kakihara T; Kamishima T; Ohnishi Y; Naito M; Kishi K; Shibata A Leuk Res; 1993 Apr; 17(4):325-32. PubMed ID: 8387619 [TBL] [Abstract][Full Text] [Related]
5. Induction of surface antigen recognized by new monoclonal antibody, YU311, on 1-beta-D-arabinofuranosylcytosine-resistant human leukemic cell line. Kakihara T; Yamada T; Fukuda T; Ohnishi Y; Kishi K; Uchiyama M; Shibata A Leuk Res; 1993 Jun; 17(6):541-5. PubMed ID: 8505852 [TBL] [Abstract][Full Text] [Related]
6. Role of free radicals in an adriamycin-resistant human small cell lung cancer cell line. Meijer C; Mulder NH; Timmer-Bosscha H; Zijlstra JG; de Vries EG Cancer Res; 1987 Sep; 47(17):4613-7. PubMed ID: 3040227 [TBL] [Abstract][Full Text] [Related]
7. Multidrug resistant HOB1 lymphoma cells express P-glycoprotein that does not play the major role in the development of drug resistance to adriamycin. Lee WP; Lee CL; Kao MC Biochem Biophys Res Commun; 1992 Nov; 189(1):92-100. PubMed ID: 1360209 [TBL] [Abstract][Full Text] [Related]
8. Characterization of adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein. Chen YN; Mickley LA; Schwartz AM; Acton EM; Hwang JL; Fojo AT J Biol Chem; 1990 Jun; 265(17):10073-80. PubMed ID: 1972154 [TBL] [Abstract][Full Text] [Related]
9. Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression. Chao CC FEBS Lett; 1995 Oct; 373(3):285-90. PubMed ID: 7589484 [TBL] [Abstract][Full Text] [Related]
10. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells. Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311 [TBL] [Abstract][Full Text] [Related]
11. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity. David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791 [TBL] [Abstract][Full Text] [Related]
12. A study of the mechanism of resistance to Adriamycin in vivo. Glutathione metabolism, P-glycoprotein expression, and drug transport. Lee FY; Sciandra J; Siemann DW Biochem Pharmacol; 1989 Nov; 38(21):3697-705. PubMed ID: 2574574 [TBL] [Abstract][Full Text] [Related]
13. [Establishment of Drug-resistant Acute Lymphoblastic Leukemic Cell Lines and Their Resistance Mechanism]. Li TT; Zhang L; Tao SD; Ma JJ; Yu L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):698-704. PubMed ID: 29950206 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms involved in the development of adriamycin resistance in human leukemic cells. Kato S; Ideguchi H; Muta K; Nishimura J; Nawata H Leuk Res; 1990; 14(6):567-73. PubMed ID: 1973751 [TBL] [Abstract][Full Text] [Related]
15. Molecular cytogenetic characterization of drug-resistant leukemia cell lines by comparative genomic hybridization and fluorescence in situ hybridization. Shimizu H; Fukuda T; Ghazizadeh M; Nagashima M; Kawanami O; Suzuki T Jpn J Cancer Res; 2002 Aug; 93(8):902-10. PubMed ID: 12716468 [TBL] [Abstract][Full Text] [Related]
16. Vincristine-resistant human leukemia cell line: new monoclonal antibodies to a 65kDa membrane protein. Kakihara T; Yamada T; Fukuda T; Ohnishi Y; Kishi K; Shibata A Leuk Lymphoma; 1992 May; 7(1-2):157-64. PubMed ID: 1472928 [TBL] [Abstract][Full Text] [Related]
17. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance. Léonce S; Pierré A; Anstett M; Pérez V; Genton A; Bizzari JP; Atassi G Biochem Pharmacol; 1992 Nov; 44(9):1707-15. PubMed ID: 1360210 [TBL] [Abstract][Full Text] [Related]
18. Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines. Lai GM; Moscow JA; Alvarez MG; Fojo AT; Bates SE Int J Cancer; 1991 Nov; 49(5):688-95. PubMed ID: 1682279 [TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase and glutathione peroxidase are essential in the early stage of adriamycin resistance before P-glycoprotein overexpression in HOB1 lymphoma cells. Lee WP; Lee CL; Lin HC Cancer Chemother Pharmacol; 1996; 38(1):45-51. PubMed ID: 8603451 [TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines. Lai GM; Chen YN; Mickley LA; Fojo AT; Bates SE Int J Cancer; 1991 Nov; 49(5):696-703. PubMed ID: 1682280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]